Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency1, and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Other Health
Health
Cosmetics
Retail
Pharmaceutical
Galderma Group AG